Peterson Katharine
SEC CIK 2022214 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACRV | Acrivon Therapeutics, Inc. | CAO | 18.0K | — | $203.01 | 11 | 2024-05-14 | 2026-08-18 |
Most active insiders at ACRV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Blume-Jensen Peter | Pres, CEO, Dir | $82.3K | $34.4K |
| 2 | Devroe Eric | COO | $17.2K | $1,214 |
| 3 | Levy Adam D. | CFO | $15.0K | $1,793 |
| 4 | Miller Mary | CLO | — | $1,380 |
| 5 | Gamelin Erick | Chief Development Off | — | $804.00 |
| 6 | Peterson Katharine | CAO | — | $203.01 |
| 7 | Levin Michaela | Chief Business Off | — | — |
| 8 | Palani Santhosh | Dir | — | — |
| 9 | Masson Kristina | EVP - Business Ops, Dir | — | — |
| 10 | DiRocco Derek | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-20 16:10 | 2026-08-18 | ACRV | Acrivon Therapeutics, Inc. | Peterson Katharine | CAO | S - Sale | $2.01 | -101 | 18.0K | -0.6% | -$203.01 | |
| 2026-05-20 16:31 | 2026-05-18 | ACRV | Acrivon Therapeutics, Inc. | Peterson Katharine | CAO | A - Grant | $0.00 | +14.2K | 18.1K | +364% | $0 | |
| 2026-05-18 16:11 | 2026-05-14 | ACRV | Acrivon Therapeutics, Inc. | Peterson Katharine | CAO | F - Tax | $1.92 | -99 | 3,907 | -2% | -$190.08 | |
| 2026-02-18 | 2026-02-14 | ACRV | Acrivon Therapeutics, Inc. | Peterson Katharine | CAO | F - Tax | $1.63 | -116 | 4,006 | -3% | -$189.08 | |
| 2025-11-18 | 2025-11-14 | ACRV | Acrivon Therapeutics, Inc. | Peterson Katharine | CAO | F - Tax | $2.24 | -99 | 4,122 | -2% | -$221.76 | |
| 2025-08-18 | 2025-08-14 | ACRV | Acrivon Therapeutics, Inc. | Peterson Katharine | CAO | F - Tax | $1.39 | -99 | 4,221 | -2% | -$137.61 | |
| 2025-05-16 | 2025-05-14 | ACRV | Acrivon Therapeutics, Inc. | Peterson Katharine | CAO | F - Tax | $1.14 | -99 | 4,320 | -2% | -$112.86 | |
| 2025-02-19 | 2025-02-14 | ACRV | Acrivon Therapeutics, Inc. | Peterson Katharine | CAO | F - Tax | $5.42 | -116 | 4,419 | -3% | -$628.72 | |
| 2024-11-18 | 2024-11-14 | ACRV | Acrivon Therapeutics, Inc. | Peterson Katharine | CAO | F - Tax | $7.92 | -99 | 4,535 | -2% | -$784.08 | |
| 2024-08-16 | 2024-08-14 | ACRV | Acrivon Therapeutics, Inc. | Peterson Katharine | CAO | F - Tax | $7.02 | -99 | 4,634 | -2% | -$694.98 | |
| 2024-05-16 | 2024-05-14 | ACRV | Acrivon Therapeutics, Inc. | Peterson Katharine | CAO | F - Tax | $8.36 | -99 | 4,733 | -2% | -$827.64 |
Purchase Sale Sale after option exercise All abbreviations